Who
Cristin Rothfuss
EVP, General Counsel
Company insider
Files Form 4 as: EVP, General Counsel, Sarepta Therapeutics.
In numbers
- Trades disclosed
- 23
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 26 Nov 2024
- Last trade
- 4 Sep 2026
- Last filed
- 8 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Sep 2026filed 8 Sep 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $489K22,025 at $22.22 | filing |
| 4 Sep 2026filed 8 Sep 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $489K22,025 at $22.22 | filing |
| 11 Mar 2026filed 13 Mar 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $17K974 at $17.03 | filing |
| 11 Mar 2026filed 13 Mar 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $17K974 at $17.03 | filing |
| 9 Mar 2026filed 11 Mar 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $8,204484 at $16.95 | filing |
| 9 Mar 2026filed 11 Mar 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $5,865346 at $16.95 | filing |
| 9 Mar 2026filed 11 Mar 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $8,204484 at $16.95 | filing |
| 9 Mar 2026filed 11 Mar 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $5,865346 at $16.95 | filing |
| 2 Mar 2026filed 3 Mar 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $6,610408 at $16.20 | filing |
| 2 Mar 2026filed 3 Mar 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $6,610408 at $16.20 | filing |
| 28 Nov 2025filed 2 Dec 2025 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $4,836229 at $21.12 | filing |
| 3 Sep 2025filed 5 Sep 2025 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code A | —93,875 at $0.00 | filing |
| 3 Sep 2025filed 5 Sep 2025 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | SRPT Sarepta Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,644 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $49K491 at $100.13 | filing |
| 10 Mar 2025filed 11 Mar 2025 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code A | —8,276 | filing |
| 7 Mar 2025filed 10 Mar 2025 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $117K1,131 at $103.70 | filing |
| 7 Mar 2025filed 10 Mar 2025 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $36K347 at $103.70 | filing |
| 4 Mar 2025filed 6 Mar 2025 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $29K288 at $101.34 | filing |
| 4 Mar 2025filed 6 Mar 2025 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $30K296 at $101.34 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.